b'AuthorsMichael Jones, Partnermjones@goodwinlaw.com +1 617 570 1978Michael Jones focuses his securities litigation practice on working with technology and life sciences clients. He represents clients in shareholder and derivative lawsuits, alleging violations of the Securities Exchange Act, as well as regulatory, civil and criminal investigations by the SEC, Department of Justice, SROs and state attorneys general. Mr. Jones has been recognized by the Daily Journal as one of Californias top 40 Under 40 lawyers, listed in The Legal 500 U.S., and recognized as a Super Lawyer Rising Star for his representation of clients in shareholder and derivative lawsuits, alleging violations of the Securities Exchange Act, as well as regulatory, civil and criminal investigations by the SEC, Department of Justice, SROs and state attorneys general, including allegations of accounting fraud, insider trading, violations of the Foreign Corrupt Practices Act, and disclosure violations, among others.Caroline Bullerjahn, Partnercbullerjahn@goodwinlaw.com +1 617 570 1359Caroline Bullerjahn focuses her securities litigation practice on class action and derivative litigation defense; SEC, DOJ, and other regulatory and internal investigations; fiduciary duty claims, and corporate governance matters, and shareholder disputes; and M&A-related litigation and post-closing disputes. She primarily represents public technology, life sciences and healthcare companies, and their directors and officers. In addition, she advises clients and their boards of directors on disclosure-related issues and litigation risk mitigation measures. Ms. Bullerjahn has been recognized as a Rising Star by the National Law Journal for her representation of both private and publicly traded corporations, primarily in the life sciences, biotechnology, medical device, healthcare and technology industries, and their officers and directors in such securities litigation matters.Nicole Chessari, Counselnchessari@goodwinlaw.comNicole Chessari is a Counsel in the firms Litigation Department and a member of its Securities Litigation practice, with a focus on working with technology and life sciences companies and venture capital firms. She specializes in defending companies, directors, and executives against securities class actions, derivative lawsuits, and M&A litigation, and representing companies and individuals in complex commercial disputes.94'